NOVTNovanta Inc.

$145.03+28% 1Y

$145.03

$99.2252 weeks$168.82

NOVT in its own filings

NOVT's filing record carries 4 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.

548

Events found in the filings · across 1,551 filings · the record starts in 1999

Hard flags: 4
Hard flags
Most recent filing: Oct 2, 2026
Most recent filing · Form 8-K/A
Record starts: Mar 31, 1999
Record starts · the earliest filing Ryufin holds for this name

Details›

Next results filingsame week as a year ago: expected around Nov 2, 2026
Restatement admitted (non-reliance)3 occurrences: 2009-03-30
Bankruptcy or receivership2 occurrences: 2010-05-28
Change in certifying accountant3 occurrences: 2024-03-15
Late periodic report11 occurrences: 2010-11-15
Delisting notice / listing-rule failure10 occurrences: 2010-03-19
Security removed from listing or deregisteredhistorical · usually a matured note or preferred class, not the common shares: 2010-04-05
Material impairmenthistorical: 2015-01-12
SEC comment-letter activity9 occurrences: 2011-01-20

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

Oct 2, 2026Consolidated Financial Statements and Report of Independent Certified Public Accountants.Material event (exhibits only) · press release
Aug 5, 2026Novanta Announces Financial Results.Earnings release · press release
Jul 27, 2026As previously disclosed in the Current Report on Form 8-K filed on June 8, 2026 (the “Previous Form 8-K”), by Novanta Inc., a Canadian corporation (the “Company”) with the Securities and Exchange Commission, on June 8, 2026, the Company, Novanta Medical Technologies Corp., a Delaware corporation and an indirect …Acquisition or disposition completed · Form 8-K
Jun 9, 2026On June 8, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) for a private placement (the “Private Placement”) with certain institutional and other accredited investors (each, a “Purchaser” and collectively, the “Purchasers”)Material agreement entered · Form 8-K
Jun 9, 2026Equity Purchase Agreement On June 8, 2026, Novanta Inc., a Canadian corporation (the “Company”), Novanta Medical Technologies Corp., a Delaware corporation and an indirect subsidiary of the Company (“Buyer”), Novanta Corporation, a Michigan corporation (“Intermediate Parent”, and together with the Company and the …Material agreement entered · Form 8-K
May 15, 2026On May 15, 2026 (the “Second Amendment Effective Date”), Novanta Inc. (the “Company”), Novanta Corporation (the “Lead Borrower”), Novanta UK Investments Holding Limited (the “U.K. Borrower”), Novanta Europe GmbH (the “German Borrower” and, together with the Company, the Lead Borrower and the U.K. Borrower, the …Material agreement entered · Form 8-K
May 11, 2026Novanta Announces Financial Results.Earnings release · press release
Feb 23, 2026Novanta Announces Financial Results.Earnings release · press release
Nov 12, 2025Underwriting Agreement On November 6, 2025, the Company entered into an underwriting agreement (the “Underwriting Agreement”), among the Company and J.P. Morgan Securities LLC and BofA Securities, Inc., as representatives (the “Representatives”) of the several underwriters (the “Underwriters”), pursuant to which the …Material agreement entered · Form 8-K